Cornell Alison A

Director Cornell buys 11,709 shares of ZIVO at $8.54; stock at $9.00, down 58.1% from $21.49 peak; prior 2 buys perfectly timed (90d: +85.8%, +558.3%)

Director Alison A Cornell purchased 11,709 shares at $8.54, raising her stake by 4.4% to 279,481 shares post-transaction. The stock is currently trading at $9.00, down 58.1% from its 52-week high of $21.49 and down 35.7% over the past 90 days, suggesting a sharp drawdown. Cornell's prior buying activity at ZIVO demonstrates strong timing: her 2024-08-22 buy returned +85.8% over 30 days and +151.3% over 90 days, while her 2024-01-02 buy returned +558.3% over 30 days and +524.9% over 90 days—both well-timed entries. This current purchase occurs alongside 3 other insider buys within the past 14 days, forming a cluster pattern. The company is unprofitable (full-year net income was negative) with only $65.6K in latest quarterly revenue, though annual revenue growth reaches +468.6%. Cornell's consistent track record of well-timed entries at this ticker is notable, but the stock's recent steep decline and the company's weak fundamentals warrant close observation of whether this accumulation phase signals a genuine inflection point.

Director Cornell buys 11,990 shares of ZIVO at $8.34 for $100.0K; stock down 28.4% from 52-week high despite director's prior buy gaining 524.9% at 90 days.

Director Alison A Cornell purchased 11,990 shares at $8.34 on 2024-08-22, increasing her holdings by 4.9% to 257,975 shares. The stock has declined 28.4% from its 52-week high of $11.52 and is trading 0.11 below the purchase price at $8.25. Notably, Cornell has a strong track record: her prior buy at ZIVO on 2024-01-02 delivered a 90-day return of 524.9%, representing a 1-of-1 pattern of well-timed purchases at the 90-day mark. However, the company remains unprofitable with a $-8.2M net loss in the latest quarter and zero revenue, and the stock is down 2.4% over the past 30 days despite being up 3.4% over 90 days—meaning the recent momentum has stalled considerably. This purchase occurs near a meaningful 52-week price trough, aligning with the timing of her previous successful buy, but the fundamental picture remains challenged.